Rebalix
Logo AmundiAmundi · sheet of 10 September 2026
ETF sheet · official issuer and register data

Amundi PEA S&P US Industrials Screened UCITS ETF - Acc

PDJE · FR0011869270 · class Acc · EUR · domicile France
Equity · United States · Industrials · Large cap · Sustainable / ESGSFDR art. 8
Index tracked: S&P 500 Plus Industrials Enhanced Weighted & Screened Index
TER
0.50%+ trans. 0.00%
Fund size
86 m EUR
Tracking difference
−0.75%3-year avg
🇮🇹 tax rate
white list not published
Replication
Synthetic (swap)
Income
Accumulating
Launch 13 May 2014 · costs from the KID as of 2 Sept 2026 · 28 securities held · 5 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The Fund is a passively managed index-based UCITS. The Fund promotes environmental and/or social characteristics within the meaning of Article 8 of the Disclosure Regulation. The Fund's objective is to replicate, both upwards and downwards, the performance of the S&P 500 Plus Industrials Enhanced Weighted & Screened Index (the "Index"), denominated in USD, while minimising the tracking error between the Fund's performance and that of the Index. The expected level of the tracking error under normal market conditions is indicated in the Fund prospectus.…

Performance since series start (in euro) — base 100

13 May 20148 Sept 2026 · dividends reinvested where declared by the issuer
20152017201920212023202549099462
High 490 (27 Jul 2026) · low 99 (19 May 2014) · last 462. Past performance is not indicative of future results.

Returns in euro

1 year+19.1%
3 years+50.9%
5 years+68.9%
10 years+228.7%
Since series start+362.2%

Risk · 1 / 3 / 5 years

Volatility (ann.)17.83%18.42%17.75%
Max drawdown−10.64%−23.83%−23.83%
Sharpe0.960.680.55
Sortino1.420.990.78
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · PDJE · FR00118692701
RebalixPDJE · FR0011869270 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+1.86%+2.78%−0.92%
2024+22.97%+24.03%−1.05%
2023+8.96%+9.24%−0.28%
2022−1.49%−1.38%−0.11%
2021+29.33%+29.41%−0.08%

Holdings

Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 1 Sept 2026 · 28 securities · top-10 weight = 56.6%
Top holdingsWeight
EDP SA9.1%
DSV A/S (DKK)7.7%
ORSTED A/S6.9%
PANDORA A/S (DKK)5.5%
TELENOR ASA4.9%
TRYG A/S4.8%
GENMAB A/S4.5%
JERONIMO MARTINS4.5%
SANDVIK AB4.4%
VOLVO AB-B SHS4.4%

Listing venues

ESMA register (FIRDS) and official exchange lists
L8IV · Börse Düsseldorf, Börse Hamburg, Börse Hannover, Börse Stuttgart
PDJE · Euronext Paris
+ 17 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.it/pdfDocuments/kid-priips/FR0011869270/ENG/NLD
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/FR0011869270/FRA/FRA/I
Prospectus · www.amundietf.nl/pdfDocuments/prospectus/FR0011869270/ENG/NLD
The live sheet, always up to date
rebalix.com/en/etf/FR0011869270
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · PDJE · FR00118692702